Table 2.
Comparison between single and combined approaches in ORIF and DM-CHP group
| ORIF | DM-CHP | |||||
|---|---|---|---|---|---|---|
| SA-ORIF | CA-ORIF | P value | SA-CHP | CA-CHP | P value | |
| n = 21 | n = 4 | n = 18 | n = 8 | |||
| Intra-operative blood loss (ml), median | 500 | 1000 | 0.16 | 800 | 1000 | 0.04 |
| (ml), (range) | (200–1800) | (250–1750) | (369–1100) | (400–1700) | ||
| Surgery time (minutes), median | 110 | 145 | 0.06 | 168 | 212.5 | 0.04 |
| (minutes), (range) | (54–305) | (107–246) | (106–272) | (165–250) | ||
| Early medical complications, n (%) | 6 (28.6%) | 2 (50%) | 0.34 | 2 (11.1%) | 6 (75%) | 0.003 |
| Pulmonary embolism | 0 | 0 | 0 | 2 (25%) | ||
| Deep vein thrombosis | 1 (4.8%) | 0 | 0 | 0 | ||
| Pulmonary infection | 1 (4.8%) | 1 (25%) | 0 | 2 (25%) | ||
| Cardiac distress | 0 | 0 | 0 | 1 (12.5%) | ||
| Cicatrization disorder | 1 (4.8%) | 0 | 0 | 0 | ||
| Urinary tract infection | 1 (4.8%) | 0 | 2 (11.1%) | 0 | ||
| Nerve injuries | 1 (4.8%) | 1 (25%) | 0 | 0 | ||
| Myocardial infarction | 1 (4.8%) | 0 | 0 | 0 | ||
| Haemorrhagic shock | 0 | 0 | 0 | 1 (12.5%) | ||
| Surgical site infection, n (%) | 0 | 1 (16.7%) | 0.24 | 2 (11.1%) | 0 | 1.00 |
| Revision, n (%) | 3 (14.3%) | 2 (50%) | 0.23 | 2 (11.1%) | 0 | 0.53 |
| Secondary THA | 3 (14.3%) | 1 (16.7%) | 0 | 0 | ||
| Surgical site infection | 0 | 1 (16.7%) | 2 (11.1%) | 0 | ||
| Heterotopic ossification, n (%) | 5 (23.8%) | 2 (50%) | 1.00 | 5 (27.8%) | 1 (12.5%) | 0.63 |
ORIF open reduction internal fixation, DM-CHP dual mobility-combined hip procedure,
SA-ORIF single approach ORIF, CA-ORIF combined approach ORIF, SA-CHP single approach DM-CHP,
CA-CHP combined approach DM-CHP, THA total hip arthroplasty